Research Area
|
Description
|
Cancer |
Biological Activity
|
Description
|
PIK-293 is a PI3-K inhibitor for p110α, p110β, p110δ and p110γ with IC50 of 100 μM, 25 μM, 0.24 μM and 10 μM, respectively. |
Targets
|
p110α |
p110β |
p110δ |
p110γ |
|
|
IC50 |
100 μM |
25 μM |
0.24 μM |
10 μM [1] |
|
|
In Vitro
|
PIK-293 is a pyrazolopyrimidine analog of IC87114. PIK-293 is synthesized by replacing the adenine of IC87114 with the isosteric pyrazolopyrimidine. [1] |
In Vivo
|
|
Clinical Trials
|
|
Features
|
|
|